Put Osteonecrosis of the Jaw Risk in Perspective

June 2023

Questions are still popping up about the risk of osteonecrosis of the jaw due to meds.

About 20 years ago, the first cases of med-related osteonecrosis of the jaw were reported after bisphosphonate use.

These patients develop persistent exposed bone...or a fistula down to the bone...in the upper or lower jaw.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Navigate Ongoing COVID-19 Vaccine Changes
Dermatology Educate About Skin Cancer Detection and Protection
Cholesterol Think “Lower Is Better” for LDL in Patients at High CV Risk
Med Adherence Tailor Approaches to Improve Med Adherence
Diabetes Individualize Sick Day Management for Diabetes
Storage & Disposal Avoid Removing Some Meds From Their Original Container
Med Safety Put Osteonecrosis of the Jaw Risk in Perspective
Dermatology Clarify the Role of OTC and Rx Options for Poison Ivy
Pediatrics Address the Rise in Childhood Obesity